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To the editor: 
The systematic literature analysis and review by R Köck 
et al. [1] on targeted preventive measures to limit infec-
tions by meticillin-resistant Staphylococcus aureus 
(MRSA) is well done but surprisingly did not include the 
single most extensive intervention published to date, 
i.e. the Veterans Affairs (VA) initiative to combat MRSA 
in their acute care hospitals in the United States [2]. The 
introduction in the summer of 2007 of active screening, 
followed by contact isolation of positive patients, led 
to an impressive 62% decrease in MRSA infection in 
their intensive care units (ICUs) and a 45% reduction in 
non-ICU wards by the end of 2010. These reductions in 
MRSA infection rates were sustained and even reached 
72% for ICU’s and 65% for non-ICU’s by June 2012 [3]. 
Nation-wide, virtually all (150/153) VA hospitals par-
ticipated in this effort and millions of patients were 
screened, far surpassing the combined experiences of 
all studies that were included in the Köck review. Of 
note, such rapid positive effects of active MRSA sur-
veillance and contact isolation are concordant with the 
predictions previously made by Bootsma et al. from 
their complex modelling of the MRSA epidemiology in 
acute care hospitals [4]. Interestingly, the same inter-
vention was applied to all the 133 VA long term care 
facilities in 2009 and this led to a 36% reduction in 
MRSA infections in these facilities by the end of 2012 
[5]. In that latter intervention, 12.9 million resident 
days were monitored.
The first evaluation of the VA initiative was mentioned 
by Köck et al., but only briefly in the discussion sec-
tion of their review (reference 99 in their paper), but it 
remains to be explained why the VA initiative’s experi-
ence was not included in the body of the review and 
presented in the Tables. The fact that the VA initiative 
was not primarily designed as a study but as a real-
life intervention does not make it irrelevant for this 
review. The intervention was well executed (with very 
high compliance rates), closely monitored and did have 
pre- and post-intervention phases. As stated by Köck 
et al., very few randomised controlled trials have been 
done on MRSA control, and most data included in their 
Tables were derived from similar quasi-experimental 
observational studies [1]. As the Review is now, the 
readership may fail to learn about the highly instruc-
tive VA MRSA prevention initiative.
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